ZA200410249B - Modified 2' and 3'-nucleoside prodrugs for treating Flaviviridae infections - Google Patents

Modified 2' and 3'-nucleoside prodrugs for treating Flaviviridae infections

Info

Publication number
ZA200410249B
ZA200410249B ZA200410249A ZA200410249A ZA200410249B ZA 200410249 B ZA200410249 B ZA 200410249B ZA 200410249 A ZA200410249 A ZA 200410249A ZA 200410249 A ZA200410249 A ZA 200410249A ZA 200410249 B ZA200410249 B ZA 200410249B
Authority
ZA
South Africa
Prior art keywords
modified
flaviviridae infections
nucleoside prodrugs
treating flaviviridae
treating
Prior art date
Application number
ZA200410249A
Other languages
English (en)
Inventor
Sommadossi Jean-Pierre
Storer Richard
La Colla Poalo
Gosselin Gilles
Original Assignee
Idenix Cayman Ltd
Univ Cagliari
Centre Nat Rech Scient
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36707321&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA200410249(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Idenix Cayman Ltd, Univ Cagliari, Centre Nat Rech Scient filed Critical Idenix Cayman Ltd
Publication of ZA200410249B publication Critical patent/ZA200410249B/xx

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
ZA200410249A 2002-06-28 2004-12-20 Modified 2' and 3'-nucleoside prodrugs for treating Flaviviridae infections ZA200410249B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US39235002P 2002-06-28 2002-06-28

Publications (1)

Publication Number Publication Date
ZA200410249B true ZA200410249B (en) 2008-10-29

Family

ID=36707321

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200410249A ZA200410249B (en) 2002-06-28 2004-12-20 Modified 2' and 3'-nucleoside prodrugs for treating Flaviviridae infections

Country Status (2)

Country Link
CN (2) CN1761677A (zh)
ZA (1) ZA200410249B (zh)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0419345B8 (pt) 2003-05-30 2021-05-25 Gilead Pharmasset Llc uso do (2’r)-2’-desoxi-2’-flúor-2’-c-metil nucleosídeo e de uma composição farmacêutica que o compreende
US7964580B2 (en) * 2007-03-30 2011-06-21 Pharmasset, Inc. Nucleoside phosphoramidate prodrugs
CN102702141A (zh) * 2012-05-23 2012-10-03 济南圣泉唐和唐生物科技有限公司 一种2-c-甲基-d-核糖酸-1,4-内酯的制备方法
AU2014311827B2 (en) 2013-08-27 2017-09-14 Gilead Sciences, Inc. Combination formulation of two antiviral compounds
AU2018335411B2 (en) * 2017-09-21 2024-06-27 Riboscience Llc 4'-fluoro-2'-methyl substituted nucleoside derivatives as inhibitors of HCV RNA replication
CN113861249B (zh) * 2021-10-27 2024-03-19 江苏福瑞康泰药业有限公司 一种索非布韦中间体的合成方法
CN117343111B (zh) * 2023-12-04 2024-02-06 康羽生命科学技术(苏州)有限公司 核苷修饰物n2-异丁酰-2'-甲氧基鸟苷的制备方法

Also Published As

Publication number Publication date
CN101172992A (zh) 2008-05-07
CN1761677A (zh) 2006-04-19

Similar Documents

Publication Publication Date Title
IL165891A0 (en) 2' and 3'-nucleoside prodrugs for treating flaviviridae infections
IL165893A0 (en) Modified 2' and 3'-nucleoside prodrugs for treating flaviridae infections
AP2005003213A0 (en) 2'-C-methyl-3'-O-L-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections.
ZA200410290B (en) 2'-C-methyl-3'-O-L-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections
EP1558321A4 (en) MASK AND ASSOCIATED COMPONENTS
IL173439A0 (en) [1,8]naphthyridin-2-ones and related compounds for the treatment of schizophrenia
EP1391476A4 (en) PHOTOREACTIVE COMPOSITION
HK1061212A1 (en) Pyranoindazoles and their use for the treatment ofglaucoma
GB0110288D0 (en) Composition and treatment method
HUP0303344A3 (en) Carbamate compounds for use in preventing and treating movement disorders
EP1461047A4 (en) COMPOSITIONS AND METHODS FOR TREATING ANIMALS
AU2003296963A8 (en) Methods and compositions for treating and preventing ear infections
AU2003239132A8 (en) Methods and compositions for preventing and treating microbial infections
ZA200410249B (en) Modified 2' and 3'-nucleoside prodrugs for treating Flaviviridae infections
EP1558238A4 (en) BETA-HYDROXYPHENYL ALDYLAMINE AND ITS USE FOR THE TREATMENT OF GLAUCOMA
HUP0401913A3 (en) Medicine for preventing and treating bromhidrosis
AU2003259202A8 (en) Compositions and methods for treating and preventing infection
PT1698338E (pt) S-metil-di-hidro-ziprasidona para o tratamento de distúrbios psiquiátricos
GB2397810B (en) Class 2 invalid carriage
FR2845116B1 (fr) Chassis d'ouvrant respirant
AU2002342188A8 (en) Methods and compositions for treating flavivirus-mediated disease
SI1523489T1 (sl) Modificirana 2' in 3'-nukleozidna prozdravila za zdravljenje okuĺ˝b z virusi iz druĺ˝ine flaviviridae
AU2003214606A8 (en) Compositions and methods for treating mdma-induced toxicity
ITMI20030282A1 (it) Composizione e dispositivi per l'assorbimento
GB0130694D0 (en) Treatment